Innate Pharma S.A. (LON:0EVI)
London · Delayed Price · Currency is GBP · Price in EUR 1.840
-0.140 (-7.07%)
At close: Oct 17, 2025
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
62.25K GBP
Profits / Employee
-226.87K GBP
Market Cap
147.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | 215 | -29 | -11.89% |
| Dec 31, 2020 | 244 | 9 | 3.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| BP p.l.c. | 100,500 |
| Shell | 96,000 |
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Rio Tinto Group | 60,000 |
| British American Tobacco p.l.c. | 48,989 |